Author:
Lu Taikun,Wang Hao,Liu Yang,Qin Xiaowei,Teng Yongliang,Wang Yubo
Abstract
AbstractSpinal epidural angiolipomas are rare, benign, mesenchymal tumors. It remains unclear whether spinal epidural angiolipomas are genuinely rare or merely underreported. Herein, we assessed the demographic and clinical characteristics of patients with spinal epidural angiolipoma. We collected data from patients with spinal epidural angiolipoma from three sources. First, we retrospectively analyzed data from patients diagnosed with spinal epidural angiolipoma in our hospital between January 1, 2014, and December 31, 2023. Second, we performed a literature review of studies retrieved from PubMed. Third, we retrieved detailed data of patients with spinal angiolipoma from the Surveillance, Epidemiology, and End Results (SEER) database. We conducted a descriptive analysis to investigate the demographic and clinical characteristics of patients with spinal epidural angiolipoma. At our institution, three patients were diagnosed with spinal epidural angiolipoma. Additionally, we identified 116 patients from the literature review and 15 patients from the SEER database. We reviewed the treatment history and imaging features of the three patients from our institution. The descriptive analysis of the data collected from the literature review was consistent with previous reports. For example, 63.0% of lesions were located at the thoracic level. 31.9% of these lesions involved two vertebral bodies, while 75.6% involved 2–4 vertebral bodies. The most common symptoms experienced by patients were back pain, paraparesis, and numbness in the legs. Surgery was the primary treatment option for most patients, and complete tumor resection was achieved in the majority of patients. The male:female ratio was 1:1.4, the median age at diagnosis for the patients from the literature was 49 years old, and the median follow-up was 24 months. Notably, most of the reports came from Asia and there were few reports from Africa. The findings from the SEER database indicated a male:female ratio of 2:1. The peak incidence, which is typically reported in the fifth decade of life, was not observed. We presented three cases of spinal epidural angiolipoma and supplemented our findings with a literature review and population-based analysis according to the SEER database for the United States population. We believe that our research will enhance clinicians’ comprehension of this uncommon tumor.
Funder
S&T Development Planning Program of Jilin Province
Health and Wellness Technology Enhancement Project of Jilin Province
Science and technology development plan project of Jilin Province
Publisher
Springer Science and Business Media LLC
Reference82 articles.
1. Louis, D. N., Ohgaki, H., Wiestler, O. D., Cavenee, W. K. & Cancer, I. A. f. R. o. WHO Classification of Tumours of the Central Nervous System. (International Agency for Research on Cancer, 2016).
2. Samdani, A. F., Garonzik, I. M., Jallo, G., Eberhart, C. G. & Zahos, P. Spinal angiolipoma: Case report and review of the literature. Acta Neurochir. 146, 299–302. https://doi.org/10.1007/s00701-003-0196-x (2004).
3. Reyes, D. & Candocia, F. J. Thoracolumbar spinal angiolipoma demonstrating high signal on STIR imaging: A case report and review of the literature. Spine J. 13, e1-5. https://doi.org/10.1016/j.spinee.2013.06.057 (2013).
4. Pagni, C. A. & Canavero, S. Spinal epidural angiolipoma: Rare or unreported?. Neurosurgery 31, 758–764. https://doi.org/10.1227/00006123-199210000-00023 (1992).
5. Surveillance, Epidemiology, and End Results (SEER) Program (https://www.seer.cancer.gov) SEER*Stat Database: Incidence - SEER Research Limited-Field Data, 22 Registries, Nov 2022 Sub (2000–2020) - Linked To County Attributes - Time Dependent (1990–2021) Income/Rurality, 1969–2021 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, released April 2023, based on the November 2022 submission.